Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardizem CD Antitrust Ruling Should Stand, FTC Tells Supreme Court

This article was originally published in The Pink Sheet Daily

Executive Summary

Key aspects of the agreement between Andrx and Hoechst Marion Roussel, such as "reverse payments" and interim settlement, are unlikely to arise in future deals between brand and generic companies, the Federal Trade Commission and Solicitor General tell the high court.

You may also be interested in...



Supreme Court Declines To Hear Cardizem CD, Hytrin Antitrust Cases

The two cases created an apparent disagreement among the federal appellate circuits on the legality of “reverse payments” from a brand company to delay a generic’s entry.

Supreme Court Declines To Hear Cardizem CD, Hytrin Antitrust Cases

The two cases created an apparent disagreement among the federal appellate circuits on the legality of “reverse payments” from a brand company to delay a generic’s entry.

Waxman/Hatch Changes Make “Reverse Payments” Less Likely, FTC Says

The Waxman/Hatch reforms included in the 2003 Medicare Modernization Act make "reverse payment" settlements of patent litigation less likely, the Federal Trade Commission says in a Supreme Court filing.

Topics

UsernamePublicRestriction

Register

OM016204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel